Evaluating novel cardiovascular risk factors : Can we better predict heart attacks?RIDKER, P. M.Annals of internal medicine. 1999, Vol 130, Num 11, pp 933-937, issn 0003-4819Article

Toxic effects of herbal teasRIDKER, P. M.Archives of environmental health. 1987, Vol 42, Num 3, pp 133-136, issn 0003-9896Article

Discordance between meta-analyses and large-scale randomized, controlled trials : examples from the management of acute myocardial infarctionBORZAK, S; RIDKER, P. M.Annals of internal medicine. 1995, Vol 123, Num 11, pp 873-877, issn 0003-4819Article

Left ventricular hemangioma in Kasabach-Merritt syndromeGENGENBACH, S; RIDKER, P. M.The American heart journal. 1991, Vol 121, Num 1, pp 202-203, issn 0002-8703, 2 p., p.1Article

Echocardiographic diagnosis of congenital absence of the pericardium in a patient with VATER association defectsLU, C; RIDKER, P. M.Clinical cardiology (Mahwah, NJ). 1994, Vol 17, Num 9, pp 503-504, issn 0160-9289Article

Streptokinase therapy and cholesterol embolizationRIDKER, P. M; MICHEL, T.The American journal of medicine. 1989, Vol 87, Num 3, pp 357-358, issn 0002-9343, 2 p.Article

Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrythmia specialists ?STEVENSON, W. G; RIDKER, P. M.JAMA, the journal of the American Medical Association. 1996, Vol 276, Num 6, pp 481-485, issn 0098-7484Article

Factor V Leiden mutation and the risks for thromboembolic disease : A clinical perspectivePRICE, D. T; RIDKER, P. M.Annals of internal medicine. 1997, Vol 127, Num 10, pp 895-903, issn 0003-4819Article

Toxicology. Comfrey herb tea and hepatic veno-occlusive diseaseRIDKER, P. M; MCDERMOTT, W. V.Lancet (British edition). 1989, Vol 1, Num 8639, pp 657-658, issn 0140-6736, 2 p.Article

Inflammatory bio-markers and cardiovascular risk predictionBLAKE, G. J; RIDKER, P. M.Journal of internal medicine. 2002, Vol 252, Num 4, pp 283-294, issn 0954-6820Article

Fibrinolytic and inflammatory markers for arterial occlusion : The evolving epidemiology of thrombosis and hemostasisRIDKER, P. M.Thrombosis and haemostasis. 1997, Vol 78, Num 1, pp 53-59, issn 0340-6245Conference Paper

C-Reactive protein, inflammation, and coronary riskMORROW, D. A; RIDKER, P. M.The Medical clinics of North America. 2000, Vol 84, Num 1, issn 0025-7125, ix,149-161 [14 p.]Article

Clinical efficacy of an automated high-sensitivity C-reactive protein assayRIFAI, N; TRACY, R. P; RIDKER, P. M et al.Clinical chemistry (Baltimore, Md.). 1999, Vol 45, Num 12, pp 2136-2141, issn 0009-9147Article

Hemostatic risk factors for coronary heart diseaseRIDKER, P. M; HENNEKENS, C. H.Circulation (New York, N.Y.). 1991, Vol 83, Num 3, pp 1098-1100, issn 0009-7322, 3 p.Article

Plasma concentration of lipoprotein(a) and the risk of future strokeRIDKER, P. M; STAMPFER, M. J; HENNEKENS, C. H et al.JAMA, the journal of the American Medical Association. 1995, Vol 273, Num 16, pp 1269-1273, issn 0098-7484Article

Plasma concentration of Soluble vascular cell adhesion molecule-1 and subsequent cardiovascular riskDE LEMOS, J. A; HENNEKENS, C. H; RIDKER, P. M et al.Journal of the American College of Cardiology. 2000, Vol 36, Num 2, pp 423-426, issn 0735-1097Article

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarctionRIDKER, P. M; GLYNN, R. J; HENNEKENS, C. H et al.Circulation (New York, N.Y.). 1998, Vol 97, Num 20, pp 2007-2011, issn 0009-7322Article

False positive mononucleosis screening test results associated with klebsiella hepatic abscessRIDKER, P. M; ENDERS, G. H; LIFTON, R. P et al.American journal of clinical pathology. 1990, Vol 94, Num 2, pp 222-223, issn 0002-9173Article

Cholesteryl EsterTransfer Protein Polymorphisms, Statin Use, and Their Impact on Cholesterol Levels and Cardiovascular EventsLEUSINK, M; ONLAND-MORET, N. C; CHASMAN, D. I et al.Clinical pharmacology and therapeutics. 2014, Vol 95, Num 3, pp 314-320, issn 0009-9236, 7 p.Article

Long-term effects of pravastatin on plasma concentration of C-reactive proteinRIDKER, P. M; RIFAI, N; PFEFFER, M. A et al.Circulation (New York, N.Y.). 1999, Vol 100, Num 3, pp 230-235, issn 0009-7322Article

G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US menRIDKER, P. M; HENNEKENS, C. H; MILETICH, J. P et al.Circulation (New York, N.Y.). 1999, Vol 99, Num 8, pp 999-1004, issn 0009-7322Conference Paper

Inflammation, atherosclerosis, and cardiovascular risk : an epidemiologic viewRIDKER, P. M.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S9-S12, issn 0957-5235, SUP1Conference Paper

Factor V Leiden mutation as a risk factor for Recurrent pregnancy lossRIDKER, P. M; MILETICH, J. P; BURING, J. E et al.Annals of internal medicine. 1998, Vol 128, Num 12, pp 1000-1003, issn 0003-4819, 1Article

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy menRIDKER, P. M; HENNEKENS, C. H; ROITMAN-JOHNSON, B et al.Lancet (British edition). 1998, Vol 351, Num 9096, pp 88-92, issn 0140-6736Article

Use and effectiveness of intravenous heparin therapy for treatment of acute myocardial infarction in the elderlyKRUMHOLZ, H. M; HENNEN, J; RIDKER, P. M et al.Journal of the American College of Cardiology. 1998, Vol 31, Num 5, pp 973-979, issn 0735-1097Conference Paper